domingo, 7 de diciembre de 2014

Preventing Chronic Disease | Blood Glucose Screening Rates Among Minnesota Adults With Hypertension, Behavioral Risk Factor Surveillance System, 2011 - CDC

FULL-TEXT ►

Preventing Chronic Disease | Blood Glucose Screening Rates Among Minnesota Adults With Hypertension, Behavioral Risk Factor Surveillance System, 2011 - CDC



Preventing Chronic Disease Logo



Image of eCard



Blood Glucose Screening Rates Among Minnesota Adults With Hypertension, Behavioral Risk Factor Surveillance System, 2011

Navigate This Article

Renée S.M. Kidney, PhD, MPH; James M. Peacock, PhD, MPH; Steven A. Smith, MD

Suggested citation for this article: Kidney RS, Peacock JM, Smith SA. Blood Glucose Screening Rates Among Minnesota Adults With Hypertension, Behavioral Risk Factor Surveillance System, 2011. Prev Chronic Dis 2014;11:140204. DOI:http://dx.doi.org/10.5888/pcd11.140204External Web Site Icon.
PEER REVIEWED

Abstract

Introduction
Many US adults have multiple chronic conditions, and hypertension and diabetes are among the most common dyads. Diabetes and prediabetes prevalence are increasing, and both conditions negatively affect cardiovascular health. Early diagnosis and treatment of diabetes and prediabetes can benefit people with hypertension by preventing cardiovascular complications.
Methods
We analyzed 2011 Minnesota Behavioral Risk Factor Surveillance System data to describe the proportion of adults with hypertension screened for diabetes according to US Preventive Services Task Force Recommendations for blood glucose testing. Covariates associated with lower odds of recent screening among adults without diabetes were determined using weighted logistic regression.
Results
Of Minnesota adults with self-reported hypertension, 19.6% had a diagnosis of diabetes and 10.7% had a diagnosis of prediabetes. Nearly one-third of adults with hypertension without diabetes had not received blood glucose screening in the past 3 years. Factors associated with greater odds of not being screened in multivariable models included being aged 18 to 44 years (adjusted odds ratio [AOR], 1.77; 95% confidence interval [CI], 1.23–2.55); being nonobese, with stronger effects for normal body mass index; having no check-up in the past 2 years (AOR, 2.49; 95% CI, 1.49–4.17); having hypertension treated with medication (AOR, 2.01; 95% CI, 1.49–2.71); and completing less than a college degree (AOR, 1.45; 95% CI, 1.14–1.84). Excluding respondents with prediabetes or those not receiving a check-up did not change the results.
Conclusions
Failure to screen among providers and failure to understand the importance of screening among individuals with hypertension may mean missed opportunities for early detection, clinical management, and prevention of diabetes.

Acknowledgments

The authors acknowledge CDC grant nos. 1U58DP001974-01 (RSMK) and 1U58DP004815-01 (R.S.M.K. and J.M.P.) in supporting analyses described in this manuscript. R.S.M.K. thanks Nilka Rios-Burrows for a helpful conversation about diabetes surveillance that informed the need for this type of analysis.
Top of Page

Author Information

Corresponding Author: Renée S.M. Kidney, PhD, MPH, Minnesota Department of Health, Division of Health Promotion and Chronic Disease, Center for Health Promotion, Diabetes Unit, PO Box 64882, St Paul, MN 55164-5429. Telephone: 651-201-5429. E-mail: Renee.Kidney@state.mn.us.
Author Affiliations: James M. Peacock, Minnesota Department of Health, St Paul, Minnesota; Steven A. Smith, Mayo Clinic, Rochester, Minnesota. Dr Smith is also affiliated with the Mayo College of Medicine, Rochester, Minnesota.
Top of Page

References

  1. Ward BW, Schiller J. Prevalence of multiple chronic conditions among US adults: estimates from the National Health Interview Survey, 2010. Prev Chronic Dis 2013;10:E65. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  2. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. National Academies Press; 2001. http://www.nap.edu/catalog.php?record_id=10027. Accessed April 29, 2014.
  3. Minnesota Department of Health, Heart Disease and Stroke Prevention Unit. High blood pressure in Minnesota. 2012. http://www.health.state.mn.us/divs/hpcd/chp/cvh/documents/2012mnhypertensionfactsheet.pdf. Accessed October 22, 2014.
  4. Minnesota Diabetes Unit. Diabetes in Minnesota Fact Sheet. 2013. http://www.health.state.mn.us/diabetes/pdf/DiabetesinMinnesota-2013-final-0317.pdf Accessed October 22, 2014.
  5. Rydén L, Grant P, Anker S, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2013;34(39):3035–87. Erratum in: Eur Heart J. 2014;35(27):1824. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  6. Diabetes mellitus in adults, type 2; diagnosis and management of. Guidelines and more. Institute for Clinical Systems Improvement; 2014. https://www.icsi.org/guidelines__more/catalog_guidelines_and_more/catalog_guidelines/catalog_endocrine_guidelines/diabetes/. Accessed September 5, 2014.
  7. Norris SL, Kanasagra D, Fu R; US Preventive Services Task Force. Screening for type 2 diabetes mellitus: update of the 2003 Systematic Evidence Review for the US Preventive Services Task Force. Ann Intern Med 2008;148(11):855–68. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  8. Margolis KL, O’Connor PJ, Morgan TM, Buse JB, Cohen RM, Cushman WC, et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: The ACCORD randomized trial. Diabetes Care 2014;37:1721–8. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  9. US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148(11):846–54. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  10. Geiss L, James C, Gregg E, Albright A, Williamson D, Cowie C. Diabetes risk reduction behaviors among US adults with prediabetes. Am J Prev Med 2010;38(4):403–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  11. Casagrande S, Cowie C, Fradkin J. Utility of the US Preventive Services Task Force criteria for diabetes screening. Am J Prev Med 2013;45(2):167–74.CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  12. Dall TM, Narayan KM, Gillespie KB, Gallo PD, Blanchard TD, Solcan M, et al. Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines. Popul Health Metr 2014;12:12. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  13. Behavioral Risk Factor Surveillance System. Combined landline and cell phone weighted response rates, by state 2013. Atlanta (GA): Centers for Disease Control and Prevention; 2013. http://www.cdc.gov/brfss/annual_data/2011/response_rates_11.htm. Accessed October 1, 2013.
  14. Behavioral Risk Factor Surveillance System survey data. Atlanta (GA): Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/brfss/annual_data/annual_2011.html. Accessed September 26, 2012.
  15. Behavioral Risk Factor Surveillance System. Questionnaire. Atlanta (GA): Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/brfss/annual_data/annual_2011.html. Accessed September 26, 2012.
  16. Kilmer G, Hughes E, Zhang X, Elam-Evans L. Diabetes and prediabetes screening and prevalence among adults with coronary heart disease. Am J Prev Med 2011;40(2):159–65. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  17. American Diabetes Association. Standards of medical care in diabetes — 2013. Diabetes Care 2013;36(Suppl 1):S11–66. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  18. Montana Cardiovascular Health and Diabetes Programs. Montana clinical communication and surveillance report: predictors of blood glucose screening and pre-diabetes in Montana adults. Montana Department of Public Health and Human Services, Chronic Disease Prevention and Health Promotion Program; 2011. http://www.dphhs.mt.gov/publichealth/diabetes/documents/surveillance/Oct-Dec2009.pdf. Accessed September 19, 2014.
  19. Bureau of Chronic Disease Evaluation and Research, Bureau of Community Chronic Disease Prevention. Adult diabetes prevalence in New York state. New York State Department of Health; 2011. https://www.health.ny.gov/diseases/conditions/diabetes/docs/adult_diabetes_prevalence.pdf. Accessed September 19, 2014.
  20. Mc Laughlin J, Castrodale L, editors. Pre-diabetes and blood glucose testing in Alaska, 2008. State of Alaska epidemiology bulletin. Department of Health and Social Services; 2010. http://dhss.alaska.gov/dph/Chronic/Documents/02-Internal/b2010_13.pdf. Accessed September 19, 2014.
  21. Porter J, Love D, Peters A, Sachs J, Costello A. The basics of all-payer claims databases. A primer for states. 2014. http://www.rwjf.org/content/dam/farm/reports/issue_briefs/2014/rwjf409988. Accessed September 5, 2014.
  22. Freedman D, Bess K, Tucker H, Boyd D, Tuchman A, Wallston K. Public health literacy defined. Am J Prev Med 2009;36(5):446–51. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  23. Richards T, Montori V, Godlee F, Lapsley P, Paul D. Let the patient revolution begin. BMJ 2013;346:f2614. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  24. Okura Y, Urban L, Mahoney D, Jacobsen S, Rodeheffer R. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57(10):1096–103. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  25. Li Y, Geiss L, Burrows N, Rolka D, Albright A. Awareness of prediabetes — United States, 2005–2010. MMWR Morb Mortal Wkly Rep 2013;62(11):209–12.PubMedExternal Web Site Icon
  26. Guiding principles for diabetes care. Bethesda (MD): National Diabetes Education Program; 2009. http://ndep.nih.gov/publications/PublicationDetail.aspx?PubId=108. Accessed April, 29 2014.
  27. Martin LM, Leff M, Calonge N, Garrett C, Nelson D. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000;18(3):215–8. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  28. Egan B, Li J, Qanugo S, Wolfman T. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: National Health and Nutrition Examination Surveys 1988–2010. Circulation 2013;128:29–41. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  29. Albright A, Gregg E. Preventing type 2 diabetes in communities across the US: the National Diabetes Prevention Program. Am J Prev Med 2013;44(Suppl 4):S346–51. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  30. Lipscomb E, Finch E, Brizendine E, Saha C, Hays L, Ackermann R. Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot study. Diabetes Care 2009;32(3):394–6. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  31. Katula J, Vitolins M, Morgan T, Lawlor M, Blackwell C, Isom S, et al. The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial. Am J Prev Med 2013;44(4):S324–32. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  32. Li G, Zhang P, Wang J, Gong Q, Gregg EW, Yang Q, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2014;2(6):474–80.CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)